ATE377417T1 - Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix - Google Patents

Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Info

Publication number
ATE377417T1
ATE377417T1 AT96909707T AT96909707T ATE377417T1 AT E377417 T1 ATE377417 T1 AT E377417T1 AT 96909707 T AT96909707 T AT 96909707T AT 96909707 T AT96909707 T AT 96909707T AT E377417 T1 ATE377417 T1 AT E377417T1
Authority
AT
Austria
Prior art keywords
donors
nitric oxide
oxyd
distention
cervix
Prior art date
Application number
AT96909707T
Other languages
English (en)
Inventor
Kristof Chwalisz
Robert E Garfield
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of ATE377417T1 publication Critical patent/ATE377417T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
AT96909707T 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix ATE377417T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95250059 1995-03-14

Publications (1)

Publication Number Publication Date
ATE377417T1 true ATE377417T1 (de) 2007-11-15

Family

ID=8221039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96909707T ATE377417T1 (de) 1995-03-14 1996-03-14 Verwendung von stickstoffoxyddonoren oder - antagonisten zur regulierung der dehnung der zervix

Country Status (26)

Country Link
US (1) US6333350B1 (de)
EP (1) EP0814785B1 (de)
JP (1) JP4579349B2 (de)
KR (2) KR100434239B1 (de)
CN (1) CN1151781C (de)
AT (1) ATE377417T1 (de)
AU (1) AU713172B2 (de)
CA (1) CA2214779A1 (de)
CZ (1) CZ292395B6 (de)
DE (1) DE69637313T2 (de)
ES (1) ES2297838T3 (de)
HU (1) HUP9800826A3 (de)
ID (1) ID20742A (de)
IL (1) IL117496A (de)
IS (1) IS4555A (de)
MX (1) MX9707007A (de)
MY (1) MY116500A (de)
NO (1) NO318598B1 (de)
NZ (1) NZ305169A (de)
PL (1) PL183461B1 (de)
RU (1) RU2199346C2 (de)
SK (1) SK124197A3 (de)
TW (1) TW421594B (de)
UA (1) UA57703C2 (de)
WO (1) WO1996028145A1 (de)
ZA (1) ZA962089B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA57703C2 (uk) 1995-03-14 2003-07-15 Шерінг Актієнгезеллшафт Спосіб стимуляції та спосіб інгібування дозрівання шийки матки
EP0889724A1 (de) * 1996-02-27 1999-01-13 Rpms Technology Limited Selektive cox-2-inhibitoren zur kontrolle der wehen und der gebärmutterkontraktionen
US6232434B1 (en) 1996-08-02 2001-05-15 Duke University Medical Center Polymers for delivering nitric oxide in vivo
DE19809845A1 (de) 1998-03-03 1999-09-09 Jenapharm Gmbh S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
ITMI20002117A1 (it) * 2000-09-29 2002-03-29 Ibsa Inst Biochimique Sa Uso di sodio nitroprussiato in ostetricia e ginecologia
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
RU2267133C2 (ru) * 2004-03-04 2005-12-27 Государственное учреждение "Ивановский научно-исследовательский институт материнства и детства им. В.Н. Городкова" Минздрава России Способ диагностики угрозы преждевременных родов
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
US8828981B2 (en) 2007-02-06 2014-09-09 George Creasy Progesterone for the treatment or prevention of spontaneous preterm birth
CN102283827A (zh) * 2008-10-16 2011-12-21 四川维信医药科技有限责任公司 单硝酸异山梨酯的新用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU668107B2 (en) * 1991-09-24 1996-04-26 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
US5508045A (en) 1992-10-09 1996-04-16 The Regents Of The University Of California Method and agents for control and management of labor during pregnancy
US5895783A (en) * 1993-07-16 1999-04-20 Schering Aktiengesellschaft Treatment of preeclampsia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
PL178174B1 (pl) * 1993-11-16 2000-03-31 Garfield Robert E Kompozycje farmaceutyczne do hamowania kurczliwości macicy lub stymulowania kurczliwości macicy
US5550369A (en) 1994-02-28 1996-08-27 Electro-Pro, Inc. Triangulation position detection method and apparatus
UA57703C2 (uk) 1995-03-14 2003-07-15 Шерінг Актієнгезеллшафт Спосіб стимуляції та спосіб інгібування дозрівання шийки матки

Also Published As

Publication number Publication date
NO974204L (no) 1997-11-13
IS4555A (is) 1997-09-05
CN1151781C (zh) 2004-06-02
IL117496A0 (en) 1997-03-18
IL117496A (en) 2002-12-01
AU713172B2 (en) 1999-11-25
ID20742A (id) 1999-02-25
CZ292395B6 (cs) 2003-09-17
DE69637313D1 (de) 2007-12-20
KR100434238B1 (ko) 2004-07-16
JP4579349B2 (ja) 2010-11-10
JPH11502200A (ja) 1999-02-23
SK124197A3 (en) 1998-06-03
MX9707007A (es) 1998-06-30
HUP9800826A1 (hu) 1998-07-28
ZA962089B (en) 1997-08-27
KR20040004515A (ko) 2004-01-13
RU2199346C2 (ru) 2003-02-27
MY116500A (en) 2004-02-28
KR19980703060A (ko) 1998-09-05
TW421594B (en) 2001-02-11
CZ285197A3 (cs) 1998-03-18
NO318598B1 (no) 2005-04-18
EP0814785A1 (de) 1998-01-07
UA57703C2 (uk) 2003-07-15
CN1182366A (zh) 1998-05-20
ES2297838T3 (es) 2008-05-01
HUP9800826A3 (en) 1998-08-28
WO1996028145A1 (en) 1996-09-19
US6333350B1 (en) 2001-12-25
KR100434239B1 (ko) 2004-06-09
CA2214779A1 (en) 1996-09-19
EP0814785B1 (de) 2007-11-07
NO974204D0 (no) 1997-09-12
NZ305169A (en) 1999-10-28
PL183461B1 (pl) 2002-06-28
DE69637313T2 (de) 2008-09-04
PL322252A1 (en) 1998-01-19
AU5311796A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
DE69830513D1 (de) HEMMUNG DER p38 KINASE UNTER VERWENDUNG VON SYMMETRISCHEN UND ASYMMETRISCHEN DIPHENYLHARNSTOFFEN
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ZA963281B (en) Alpha-substituted pyrimidine-thioalkyl and alkylether compounds.
DE69637313D1 (de) Verwendung von stickstoffoxyddonoren oder -antagonisten zur regulierung der dehnung der zervix
ATE156368T1 (de) Verfahren zum vermindern von durch medizinische vorrichtungen bedingten infektionen
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
NO952469D0 (no) Terapautisk kombinasjon som inneholder interferon
DE69329559D1 (de) Verwendung von mannosephosphaten zur behandlung von fibrotischen störungen
DE69805973D1 (de) Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
ATE229331T1 (de) Inhibitoren von metazoan-parasit-proteasen
DE69814444D1 (de) Kombination von angiotensing-convertin-enzyme hemmern mit diuretikum zur behandlung von störungen der mikrozirkulation
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
NO983906D0 (no) Anvendelse av karboniske anhydraseinhibitorer for behandling av makulær ödem
NO984950D0 (no) Forbindelser med veksthormonfrigj°rende egenskaper
ATE212833T1 (de) Verwendung von stickstoffoxid-synthase-substrat und/oder -donor oder stickstoffoxidhemmer zur herstellung von medikamenten zur behandlung von störungen der uterinen kontraktilität
CZ157795A3 (en) Pharmaceutical preparations for treating prostatitis
ATE184199T1 (de) Verwendung von lokal appliziertem faktor xiii zur verhinderung von blutungen
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
FI952018A7 (fi) BHAP-yhdisteiden käyttö yhdessä muiden ei-nukleosidi-käänteistransskri ptaasi-inhibiittoreiden kanssa HIV-infektion hoitoon
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
DE68919301D1 (de) Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS.
ATE136463T1 (de) Verwendung von 1,2,3,4-tetrahydroacridinen zur behandlung von aids, sowie verbindungen
DE69222429D1 (de) Orthopädische vorrichtung zum anlegen eines verbandes oder zum unbeweglichmachen der unteren gliedmassen
Lee et al. Changes of Somatosensory Evoked Potentials in Bone Lengthening: An Experimental Study on Rabbits' Tibiae
ATE85750T1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties